These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 20210644)

  • 1. Meta-analysis of trials evaluating parenteral antimicrobial therapy for skin and soft tissue infections.
    McClaine RJ; Husted TL; Hebbeler-Clark RS; Solomkin JS
    Clin Infect Dis; 2010 Apr; 50(8):1120-6. PubMed ID: 20210644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Daptomycin versus other antimicrobial agents for the treatment of skin and soft tissue infections: a meta-analysis.
    Bliziotis IA; Plessa E; Peppas G; Falagas ME
    Ann Pharmacother; 2010 Jan; 44(1):97-106. PubMed ID: 19934396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The importance of tissue penetration in achieving successful antimicrobial treatment of nosocomial pneumonia and complicated skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus: vancomycin and linezolid.
    Stein GE; Wells EM
    Curr Med Res Opin; 2010 Mar; 26(3):571-88. PubMed ID: 20055750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of linezolid on economic outcomes and determinants of cost in a clinical trial evaluating patients with MRSA complicated skin and soft-tissue infections.
    McKinnon PS; Sorensen SV; Liu LZ; Itani KM
    Ann Pharmacother; 2006 Jun; 40(6):1017-23. PubMed ID: 16720705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Once-daily cefazolin and probenecid for skin and soft tissue infections.
    Cox VC; Zed PJ
    Ann Pharmacother; 2004 Mar; 38(3):458-63. PubMed ID: 14970368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of linezolid in methicillin-resistant Staphylococcus aureus (MRSA) complicated skin and soft tissue infection (cSSTI): a meta-analysis.
    Bounthavong M; Hsu DI
    Curr Med Res Opin; 2010 Feb; 26(2):407-21. PubMed ID: 20001574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial agents for complicated skin and skin-structure infections: noninferiority margins, placebo-controlled trials, and the complexity of clinical trials.
    Stevens DL
    Clin Infect Dis; 2009 Aug; 49(3):392-4. PubMed ID: 19555284
    [No Abstract]   [Full Text] [Related]  

  • 8. New antibiotics for the management of complicated skin and soft tissue infections: are they any better?
    Nathwani D
    Int J Antimicrob Agents; 2009 Jul; 34 Suppl 1():S24-9. PubMed ID: 19560672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Telavancin: a novel lipoglycopeptide antibiotic.
    Charneski L; Patel PN; Sym D
    Ann Pharmacother; 2009 May; 43(5):928-38. PubMed ID: 19401479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Types of urethral catheters for management of short-term voiding problems in hospitalized adults: a short version Cochrane review.
    Schumm K; Lam TB
    Neurourol Urodyn; 2008; 27(8):738-46. PubMed ID: 18951451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tigecycline: the answer to beta-lactam and fluoroquinolone resistance?
    Fraise AP
    J Infect; 2006 Nov; 53(5):293-300. PubMed ID: 16876253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Linezolid versus vancomycin for the treatment of gram-positive bacterial infections: meta-analysis of randomised controlled trials.
    Beibei L; Yun C; Mengli C; Nan B; Xuhong Y; Rui W
    Int J Antimicrob Agents; 2010 Jan; 35(1):3-12. PubMed ID: 19900794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatments for skin and soft-tissue and surgical site infections due to MDR Gram-positive bacteria.
    Stevens DL
    J Infect; 2009 Sep; 59 Suppl 1():S32-9. PubMed ID: 19766887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Empiric antimicrobial therapy for pediatric skin and soft-tissue infections in the era of methicillin-resistant Staphylococcus aureus.
    Elliott DJ; Zaoutis TE; Troxel AB; Loh A; Keren R
    Pediatrics; 2009 Jun; 123(6):e959-66. PubMed ID: 19470525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishing the role of tigecycline in an era of antimicrobial resistance.
    Schafer JJ; Goff DA
    Expert Rev Anti Infect Ther; 2008 Oct; 6(5):557-67. PubMed ID: 18847395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Community-onset methicillin-resistant Staphylococcus aureus skin and soft-tissue infections: impact of antimicrobial therapy on outcome.
    Ruhe JJ; Smith N; Bradsher RW; Menon A
    Clin Infect Dis; 2007 Mar; 44(6):777-84. PubMed ID: 17304447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical antibiotic treatment for uncomplicated skin and skin structure infections: review of the literature.
    Pangilinan R; Tice A; Tillotson G
    Expert Rev Anti Infect Ther; 2009 Oct; 7(8):957-65. PubMed ID: 19803705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of piperacillin/tazobactam in skin and soft tissue infections.
    File TM; Tan JS
    Eur J Surg Suppl; 1994; (573):51-5. PubMed ID: 7524796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meta-analysis: ertapenem for complicated intra-abdominal infections.
    Falagas ME; Peppas G; Makris GC; Karageorgopoulos DE; Matthaiou DK
    Aliment Pharmacol Ther; 2008 May; 27(10):919-31. PubMed ID: 18266994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patients included in randomised controlled trials do not represent those seen in clinical practice: focus on antimicrobial agents.
    Falagas ME; Vouloumanou EK; Sgouros K; Athanasiou S; Peppas G; Siempos II
    Int J Antimicrob Agents; 2010 Jul; 36(1):1-13. PubMed ID: 20462742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.